Regulatory expertise MB Research Laboratories offers GLP-compliant toxicology testing with alignment to OECD, ISO 10993, and US EPA OCSPP guidelines, presenting a reliable regulatory-ready partner for medical devices, pharmaceuticals, and consumer products.

NAMs leadership Strong emphasis on New Approach Methodologies and non-animal assays creates opportunities to discuss ethically driven, innovative testing strategies that can differentiate MB Research from traditional CROs and appeal to clients seeking modern safety data.

In vitro strengths Core capabilities in in vitro toxicology and irritation testing across skin, eye, phototoxicity, and sensitization position MB Research as a cost-effective, rapid option for early safety assessments and device biocompatibility for ISO 10993 projects.

Global regulatory support Experience with multi-region regulatory standards and collaborations with government and industry clients worldwide enables MB Research to support market-entry strategies, submissions, and cross-border safety data generation.

Growth opportunity With a lean team and revenue in the low multi-millions, MB Research can scale focused on expanding NAMs services, expanding in vivo/toxology study offerings, and pursuing larger pharmaceutical and medical device accounts through targeted outreach and partnerships.